Overview

Bronchodilators on the Exercise Capacity of Bronchiectasis Patients

Status:
Suspended
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The bronchodilators (BD) have been widely used in bronchiectasis (BCE) therapeutic and have been shown to be effective in improving exercise capacity in patients with chronic obstructive pulmonary disease and asthma. However their effect on the exercise capacity of patients with BCE is poorly known. Besides, their respiratory mechanics pattern is also not known neither their physical activity level (PAL). Therefore, the hypothesis of this study is that BD are effective in improving exercise capacity of BCE patients. We aim also to characterize their respiratory mechanics and to evaluate their PAL and its association to their quality of life.
Phase:
N/A
Details
Lead Sponsor:
University of Sao Paulo General Hospital
Treatments:
Bronchodilator Agents
Fenoterol
Ipratropium